Zoetis hits a new 52-week low as Zoetis stock gains 2.86 percent

Published on 10/05/2026 at 21:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zoetis stock costs EUR 63.62 on October 5, 2026 after EUR 61.85. Second-quarter revenue was USD 2.47 billion versus USD 2.50 billion estimates.

ZTS, US98978V1035, Illustration mit AI erstellt.

Zoetis (ISIN US98978V1035) was trading at EUR 63.62 at Lang & Schwarz on October 5, 2026 at 9:16 p.m. CEST, up 2.86 percent versus the prior close of EUR 61.85. The company had reached a new 52-week low of USD 69.52 on September 30, 2026, according to MarketBeat.

Guidance remains sharply reduced

Zoetis reported revenue of USD 2.47 billion for the second quarter of 2026, below the USD 2.50 billion analyst estimate and down 0.20 percent year over year, according to MarketBeat. The same report said quarterly earnings per share reached USD 1.87 against USD 1.85 expected, a USD 0.02 beat.

The company set full-year 2026 adjusted earnings-per-share guidance at USD 6.15-6.25. That outlook reflects pressure in companion animal markets, including softer veterinary visits, affordability concerns and heavier promotional activity in dermatology and parasiticides.

Pet care pressure meets portfolio support

The operating picture is uneven. Livestock revenue grew 11 percent in the second quarter of 2026, while companion animal revenue declined 6 percent, according to the company earnings summary. Diagnostics revenue increased 12 percent, providing an offset to weakness in the largest pressure point.

That mix matters because Zoetis remains a diversified animal-health company spanning medicines, vaccines, diagnostics and digital solutions. Its current market capitalization was USD 29.9 billion on October 5, 2026, while the NYSE quote stood at USD 71.36 at 3:19 p.m. ET on the same date.

Third-quarter date is set

Zoetis will host its third-quarter 2026 results webcast on November 5, 2026, at 8:30 a.m. ET, according to the company release dated September 24, 2026, published by Zoetis. The report will test whether livestock and diagnostics can continue to cushion the companion animal slowdown.

Euro quote rises after low

After-hours at Lang & Schwarz, Zoetis was trading at EUR 63.62 on October 5, 2026 at 9:16 p.m. CEST, plus 2.86 percent versus the prior close of EUR 61.85. The market capitalization was USD 29.9 billion on the same date.